直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Advised a consumer-focused private investment firm on healthcare regulatory aspects of its definitive agreement to acquire a majority stake in a skin barrier and skin health brand*

Advised a consumer-focused private investment firm on healthcare regulatory aspects of its definitive agreement to acquire a majority stake in a skin barrier and skin health brand.

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Related Industries

Chemicals, Industrials, and Materials

Chemical

Consumer Goods and Services

Consumer Products

*Matter handled prior to joining Finnegan.

Related Experiences

Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Full intellectual property service for a healthcare client developing wireless communication systems

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug*

Advised a global innovator pharma company in relation to enforcement issues surrounding its second medical use patent for a chemotherapy medication*

Advised a life sciences company in navigating the patent landscape in the DNA sequencing space and preparing to clear the way for its human genomic sequencing technology*

Syneron Medical Ltd. v. EndyMed Medical Ltd.

Syneron Medical Ltd.

Experience_Preliminary_injunction_motion_denied_in_favor_of_Finnegan_client_Under_Armour

Preliminary injunction motion denied in favor of Finnegan client Under Armour

Under Armour Inc.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP